Logo image of BN

BROOKFIELD CORP (BN) Stock Fundamental Analysis

NYSE:BN - CA11271J1075 - Common Stock

65.27 USD
-0.66 (-1%)
Last: 8/25/2025, 10:02:01 AM
Fundamental Rating

3

BN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 238 industry peers in the Capital Markets industry. While BN is still in line with the averages on profitability rating, there are concerns on its financial health. BN is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

BN had positive earnings in the past year.
In the past year BN had a positive cash flow from operations.
Of the past 5 years BN 4 years were profitable.
Each year in the past 5 years BN had a positive operating cash flow.
BN Yearly Net Income VS EBIT VS OCF VS FCFBN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B 20B

1.2 Ratios

BN has a Return On Assets of 0.13%. This is in the lower half of the industry: BN underperforms 73.53% of its industry peers.
The Return On Equity of BN (1.45%) is worse than 70.17% of its industry peers.
BN's Return On Invested Capital of 3.69% is in line compared to the rest of the industry. BN outperforms 47.48% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BN is below the industry average of 7.58%.
The 3 year average ROIC (3.69%) for BN is below the current ROIC(3.69%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.13%
ROE 1.45%
ROIC 3.69%
ROA(3y)0.24%
ROA(5y)0.32%
ROE(3y)2.5%
ROE(5y)2.99%
ROIC(3y)3.69%
ROIC(5y)3.45%
BN Yearly ROA, ROE, ROICBN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8 10

1.3 Margins

BN's Profit Margin of 0.89% is on the low side compared to the rest of the industry. BN is outperformed by 71.85% of its industry peers.
BN's Profit Margin has declined in the last couple of years.
BN has a Operating Margin (26.65%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of BN has grown nicely.
BN's Gross Margin of 37.81% is on the low side compared to the rest of the industry. BN is outperformed by 67.23% of its industry peers.
BN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 26.65%
PM (TTM) 0.89%
GM 37.81%
OM growth 3Y4.81%
OM growth 5Y5.87%
PM growth 3Y-52.22%
PM growth 5Y-32.46%
GM growth 3Y8.55%
GM growth 5Y6.54%
BN Yearly Profit, Operating, Gross MarginsBN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

More info and screens

1

2. Health

2.1 Basic Checks

Compared to 1 year ago, BN has less shares outstanding
The number of shares outstanding for BN remains at a similar level compared to 5 years ago.
The debt/assets ratio for BN is higher compared to a year ago.
BN Yearly Shares OutstandingBN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
BN Yearly Total Debt VS Total AssetsBN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100B 200B 300B 400B

2.2 Solvency

BN has an Altman-Z score of 0.38. This is a bad value and indicates that BN is not financially healthy and even has some risk of bankruptcy.
BN has a worse Altman-Z score (0.38) than 67.65% of its industry peers.
A Debt/Equity ratio of 4.50 is on the high side and indicates that BN has dependencies on debt financing.
With a Debt to Equity ratio value of 4.50, BN is not doing good in the industry: 84.45% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 4.5
Debt/FCF N/A
Altman-Z 0.38
ROIC/WACCN/A
WACCN/A
BN Yearly LT Debt VS Equity VS FCFBN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50B 100B 150B

2.3 Liquidity

BN has a Current Ratio of 0.56. This is a bad value and indicates that BN is not financially healthy enough and could expect problems in meeting its short term obligations.
BN has a Current ratio of 0.56. This is in the lower half of the industry: BN underperforms 73.53% of its industry peers.
BN has a Quick Ratio of 0.56. This is a bad value and indicates that BN is not financially healthy enough and could expect problems in meeting its short term obligations.
BN has a worse Quick ratio (0.47) than 76.05% of its industry peers.
Industry RankSector Rank
Current Ratio 0.56
Quick Ratio 0.47
BN Yearly Current Assets VS Current LiabilitesBN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 0.82% over the past year.
BN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 18.12% yearly.
BN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -19.85%.
BN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.86% yearly.
EPS 1Y (TTM)0.82%
EPS 3Y-49.52%
EPS 5Y18.12%
EPS Q2Q%-34.81%
Revenue 1Y (TTM)-19.85%
Revenue growth 3Y4.33%
Revenue growth 5Y4.86%
Sales Q2Q%-21.55%

3.2 Future

The Earnings Per Share is expected to grow by 10.90% on average over the next years. This is quite good.
The Revenue is expected to grow by 20.95% on average over the next years. This is a very strong growth
EPS Next Y-2.19%
EPS Next 2Y9.03%
EPS Next 3Y10.9%
EPS Next 5YN/A
Revenue Next Year28.46%
Revenue Next 2Y21.47%
Revenue Next 3Y20.95%
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BN Yearly Revenue VS EstimatesBN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20B 40B 60B 80B
BN Yearly EPS VS EstimatesBN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 2 3 4 5

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 17.59, the valuation of BN can be described as rather expensive.
The rest of the industry has a similar Price/Earnings ratio as BN.
The average S&P500 Price/Earnings ratio is at 27.24. BN is valued slightly cheaper when compared to this.
The Price/Forward Earnings ratio is 13.83, which indicates a correct valuation of BN.
BN's Price/Forward Earnings is on the same level as the industry average.
BN's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.81.
Industry RankSector Rank
PE 17.59
Fwd PE 13.83
BN Price Earnings VS Forward Price EarningsBN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

86.97% of the companies in the same industry are more expensive than BN, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.49
BN Per share dataBN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.97
EPS Next 2Y9.03%
EPS Next 3Y10.9%

More info and screens

1

5. Dividend

5.1 Amount

BN has a yearly dividend return of 0.56%, which is pretty low.
BN's Dividend Yield is slightly below the industry average, which is at 8.00.
Compared to an average S&P500 Dividend Yield of 2.34, BN's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.56%

5.2 History

The dividend of BN decreases each year by -3.57%.
BN has been paying a dividend for at least 10 years, so it has a reliable track record.
BN has decreased its dividend recently.
Dividend Growth(5Y)-3.57%
Div Incr Years1
Div Non Decr Years1
BN Yearly Dividends per shareBN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

BN pays out 102.07% of its income as dividend. This is not a sustainable payout ratio.
DP102.07%
EPS Next 2Y9.03%
EPS Next 3Y10.9%
BN Yearly Income VS Free CF VS DividendBN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5B -10B
BN Dividend Payout.BN Dividend Payout, showing the Payout Ratio.BN Dividend Payout.PayoutRetained Earnings

More info and screens

BROOKFIELD CORP

NYSE:BN (8/25/2025, 10:02:01 AM)

65.27

-0.66 (-1%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-12 2025-11-12/bmo
Inst Owners56.07%
Inst Owner Change-0.55%
Ins Owners10.26%
Ins Owner ChangeN/A
Market Cap107.64B
Analysts76.67
Price Target73.29 (12.29%)
Short Float %1.1%
Short Ratio6.04
Dividend
Industry RankSector Rank
Dividend Yield 0.56%
Yearly Dividend0.44
Dividend Growth(5Y)-3.57%
DP102.07%
Div Incr Years1
Div Non Decr Years1
Ex-Date09-12 2025-09-12 (0.09)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.92%
Min EPS beat(2)-2.36%
Max EPS beat(2)6.19%
EPS beat(4)2
Avg EPS beat(4)3.82%
Min EPS beat(4)-2.36%
Max EPS beat(4)11.75%
EPS beat(8)6
Avg EPS beat(8)12.81%
EPS beat(12)9
Avg EPS beat(12)-0.24%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1127.6%
Min Revenue beat(2)1118.53%
Max Revenue beat(2)1136.66%
Revenue beat(4)4
Avg Revenue beat(4)1262.07%
Min Revenue beat(4)1118.53%
Max Revenue beat(4)1473.07%
Revenue beat(8)8
Avg Revenue beat(8)846.78%
Revenue beat(12)12
Avg Revenue beat(12)582.41%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)7.25%
PT rev (3m)12.03%
EPS NQ rev (1m)-1.09%
EPS NQ rev (3m)-6.74%
EPS NY rev (1m)-1.93%
EPS NY rev (3m)-2.03%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.73%
Revenue NY rev (1m)0.31%
Revenue NY rev (3m)4.1%
Valuation
Industry RankSector Rank
PE 17.59
Fwd PE 13.83
P/S 1.41
P/FCF N/A
P/OCF 10.65
P/B 2.31
P/tB N/A
EV/EBITDA 11.49
EPS(TTM)3.71
EY5.68%
EPS(NY)4.72
Fwd EY7.23%
FCF(TTM)-6.61
FCFYN/A
OCF(TTM)6.13
OCFY9.39%
SpS46.13
BVpS28.26
TBVpS-19.41
PEG (NY)N/A
PEG (5Y)0.97
Profitability
Industry RankSector Rank
ROA 0.13%
ROE 1.45%
ROCE 4.96%
ROIC 3.69%
ROICexc 3.82%
ROICexgc 4.77%
OM 26.65%
PM (TTM) 0.89%
GM 37.81%
FCFM N/A
ROA(3y)0.24%
ROA(5y)0.32%
ROE(3y)2.5%
ROE(5y)2.99%
ROIC(3y)3.69%
ROIC(5y)3.45%
ROICexc(3y)3.83%
ROICexc(5y)3.59%
ROICexgc(3y)4.77%
ROICexgc(5y)4.39%
ROCE(3y)4.96%
ROCE(5y)4.64%
ROICexcg growth 3Y2.5%
ROICexcg growth 5Y4.8%
ROICexc growth 3Y1.58%
ROICexc growth 5Y3.93%
OM growth 3Y4.81%
OM growth 5Y5.87%
PM growth 3Y-52.22%
PM growth 5Y-32.46%
GM growth 3Y8.55%
GM growth 5Y6.54%
F-Score6
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 4.5
Debt/FCF N/A
Debt/EBITDA 6.97
Cap/Depr 213.98%
Cap/Sales 27.61%
Interest Coverage 250
Cash Conversion 33.59%
Profit Quality N/A
Current Ratio 0.56
Quick Ratio 0.47
Altman-Z 0.38
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)209.51%
Cap/Depr(5y)213.66%
Cap/Sales(3y)20.38%
Cap/Sales(5y)19.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0.82%
EPS 3Y-49.52%
EPS 5Y18.12%
EPS Q2Q%-34.81%
EPS Next Y-2.19%
EPS Next 2Y9.03%
EPS Next 3Y10.9%
EPS Next 5YN/A
Revenue 1Y (TTM)-19.85%
Revenue growth 3Y4.33%
Revenue growth 5Y4.86%
Sales Q2Q%-21.55%
Revenue Next Year28.46%
Revenue Next 2Y21.47%
Revenue Next 3Y20.95%
Revenue Next 5YN/A
EBIT growth 1Y0.94%
EBIT growth 3Y9.35%
EBIT growth 5Y11.02%
EBIT Next Year485.5%
EBIT Next 3Y70.09%
EBIT Next 5YN/A
FCF growth 1Y-8.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y49.06%
OCF growth 3Y-1.38%
OCF growth 5Y3.07%